- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/4184 - 1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
Patent holdings for IPC class A61K 31/4184
Total number of patents in this class: 5020
10-year publication summary
|
347
|
378
|
337
|
367
|
410
|
335
|
314
|
356
|
324
|
208
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Boehringer Ingelheim International GmbH | 4483 |
64 |
| The Regents of the University of California | 20802 |
56 |
| Immunomedics, Inc. | 239 |
44 |
| The Johns Hopkins University | 5907 |
41 |
| Takeda Pharmaceutical Company Limited | 2712 |
41 |
| Merck Sharp & Dohme LLC | 3736 |
38 |
| Janssen Pharmaceutica N.V. | 3161 |
37 |
| Novartis AG | 10178 |
36 |
| HK Inno.n Corporation | 123 |
34 |
| Abbvie Inc. | 1822 |
33 |
| Gilead Sciences, Inc. | 2231 |
33 |
| Bristol-myers Squibb Company | 4748 |
32 |
| Boehringer Ingelheim Vetmedica GmbH | 1271 |
31 |
| Eagle Pharmaceuticals, Inc. | 102 |
31 |
| AstraZeneca AB | 2824 |
29 |
| Array BioPharma Inc. | 443 |
29 |
| Dana-Farber Cancer Institute, Inc. | 2668 |
29 |
| Achillion Pharmaceuticals, Inc. | 156 |
28 |
| Merck Sharp & Dohme Corp. | 2183 |
27 |
| Knoa Pharma LLC, Purdue Pharma, Inc., Corporation, Delaware | 85 |
24 |
| Other owners | 4303 |